Since its approval, there have been no cases of torsades de pointes or unexplained sudden death among US patients treated with Caprelsa.

On August 7, 2025, the Food and Drug Administration announced that it would be demanding the elimination of natural thyroid treatment, otherwise known as desiccated thyroid extract (DTE) or natural ...

Criswell and Dr. Abby Fleish, a pediatric endocrinologist at MaineHealth, are studying whether an older cholesterol-lowering ...

Viridian Therapeutics recently announced a royalty financing agreement with DRI Healthcare Trust, potentially unlocking up to US$300 million to support the commercial launch and development of ...

Already sky high after the success of its limb-girdle muscular dystrophy therapy, reported on Monday, BridgeBio’s shares rose nearly 8% more as encaleret balanced calcium levels in patients with a ...

Semaglutide 7 mg and 14 mg tablets are now available for reducing the risk of cardiovascular death, heart attack, or stroke ...

BBP-418 hit the mark in the phase 3 FORTIFY trial by achieving a significant increase in glycosylated alpha-dystroglycan (αDG), which is impaired in LGMD and causes muscle wasting, initially in the ...

Detailed price information for Viridian Therapeutics Inc (VRDN-Q) from The Globe and Mail including charting and trades.

Buyout bosses intend to contest any attempt by competition watchdog to disqualify them as directors of British companies ...

Iodine might be small in quantity but it is important. The mineral fuels thyroid hormones that regulate metabolism, mood, and ...

DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) ("DRI Healthcare"), a global leader in providing financing to advance innovation in the life sciences industry, has acquired a royalty interest in the U ...